Skip to main content
. 2023 Feb 13;14:1034865. doi: 10.3389/fneur.2023.1034865

Table 2.

Characteristics of all patients with or without gastrointestinal bleeding.

Characteristics non-GIB group
(N = 722)
GIB group
(n = 64)
Univariate
P value
Age, median (IQR), yrs 57 (51–66) 64 (55–71.75) 0.001
Gender 0.866
Male (N, %) 456 (63.2) 41 (64.1)
Female (N, %) 266 (36.8) 23 (35.9)
Medical history
Smoking (N, %) 80 (11.1) 7 (10.9) 0.972
Alcohol (N, %) 63 (8.7) 8 (12.5) 0.313
Hypertension (N, %) 477 (66.1) 48 (75.0) 0.146
Diabetes mellitus (N, %) 104 (14.4) 13 (20.3) 0.203
Prior anticoagulation or antiplatelet therapy (N, %) 34 (4.7) 7 (10.9) 0.032
Time from symptom onset to initial CT, hours, median (IQR) 4.0 (3.0–5.0) 4.0 (3.0–5.0) 0.542
Baseline GCS score, median (IQR) 11.0 (8.0–13.0) 9.0 (7.0–11.0) < 0.001
Baseline volume (N, %) < 0.001
< 30 ml 521 (72.2) 32 (50.0)
≥30 ml 201 (27.8) 32 (50.0)
ICH location (n, %) 0.370
Deep 500 (76.3) 52 (81.3)
Lobar 106 (14.7) 8 (12.5)
Brain stem 29 (4.0) 0 (0.0)
Cerebellum 36 (5.0) 4 (6.3)
Intraventricular hemorrhage (N, %) 187 (25.9) 13 (20.3) 0.325
Hemoglobin (g/L) 151.0 (139.0–163.0) 148.0 (136.0–169.0) 0.517
Coagulation function, median (IQR)
Platelets (109/L) 173.0 (136.0–215.0) 162.50 (129.25–190.25) 0.067
aPTT, s 24.7 (21.30–28.70) 25.70 (22.0–30.70) 0.200
INR 1.01 (0.94–1.07) 1.03 (0.95–1.09) 0.159
Prothrombin time, s 11.40 (10.80–12.0) 11.45 (10.90–12.0) 0.657
Fibrinogen, g/L 2.85 (2.40–3.40) 2.90 (2.27–3.47) 0.609
Thrombin time, s 17.40 (15.10–18.60) 17.0 (14.60–18.90) 0.363
MV used >48 h (N, %) 105 (14.5) 23 (35.9) < 0.001
Surgery (N, %) 312 (43.2) 41 (64.1) 0.001
AGR, median (IQR) 5.40 (4.31–7.11) 7.47 (5.38–9.32) < 0.001
Modified Rankin Scale (N, %) 0.005
0–2 312 (43.2%) 16 (25.0)
3–6 410 (56.8%) 48 (75.0)

AGR, age-to-GCS ratio; aPTT, activated partial thromboplastin time; CT, computed tomography; GCS, Glasgow Coma Scale; ICH, intracerebral hemorrhage; INR, international normalized ratio; IQR, interquartile range; MV, mechanical ventilation.